21 results
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
and Engineering Fair Environmental sustainability Pipeline innovation Access to medicine and fair pricing Patient advocacy Our mission: Use the power
SC TO-T/A
EX-99
DBTX
Decibel Therapeutics, Inc.
25 Sep 23
Third party tender offer statement (amended)
8:48am
, capabilities and accomplished team will further bolster Regeneron’s genetic medicines portfolio and advance our mission of helping patients around
DEFA14A
4dnzd9j6vbolxndrm8
21 Apr 22
Additional proxy soliciting materials
4:21pm
DEFA14A
u6mkrlq1 v48
23 Apr 21
Additional proxy soliciting materials
4:21pm
DEFA14A
s4ke439wp4
24 Apr 20
Additional proxy soliciting materials
4:14pm
DEFA14A
jdzbn1bxdjrbm4az
26 Apr 19
Additional proxy soliciting materials
4:08pm
8-K
EX-99.1
ogn7bm xw
10 Feb 15
Regeneron Reports Fourth Quarter and Full Year 2014 Financial and Operating Results
12:00am
8-K
EX-99.1
trplj827oleilin
12 Nov 09
Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
12:00am